US 7879324
Fusion molecules and methods for treatment of immune diseases
granted A61KA61K2039/505A61P
Quick answer
US patent 7879324 (Fusion molecules and methods for treatment of immune diseases) held by The Regents of the University of California expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/505, A61P, A61P1/04, A61P1/08